vs
PEOPLES BANCORP INC（PEBO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是PEOPLES BANCORP INC的1.7倍（$197.9M vs $118.7M），PEOPLES BANCORP INC净利率更高（24.4% vs 6.7%，领先17.7%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 3.7%）
该公司是总部位于美国明尼苏达州明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，同时也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构。它主营银行、投资、抵押贷款等相关金融业务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PEBO vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$118.7M
净利率更高
PEBO
高出17.7%
6.7%
两年增速更快
RGEN
近两年复合增速
3.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.7M | $197.9M |
| 净利润 | $29.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 24.4% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | -8.7% | 143.9% |
| 每股收益（稀释后） | $0.81 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PEBORGEN
| Q1 26 | $118.7M | — | ||
| Q4 25 | $117.3M | $197.9M | ||
| Q3 25 | $115.2M | $188.8M | ||
| Q2 25 | $114.5M | $182.4M | ||
| Q1 25 | $112.4M | $169.2M | ||
| Q4 24 | $111.6M | $174.1M | ||
| Q3 24 | $113.7M | $154.9M | ||
| Q2 24 | $110.3M | $154.1M |
净利润PEBORGEN
| Q1 26 | $29.0M | — | ||
| Q4 25 | $31.8M | $13.3M | ||
| Q3 25 | $29.5M | $14.9M | ||
| Q2 25 | $21.2M | $14.9M | ||
| Q1 25 | $24.3M | $5.8M | ||
| Q4 24 | $26.9M | $-30.3M | ||
| Q3 24 | $31.7M | $-654.0K | ||
| Q2 24 | $29.0M | $3.3M |
毛利率PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | 9.0% | ||
| Q3 25 | 33.0% | 8.9% | ||
| Q2 25 | 24.0% | 7.6% | ||
| Q1 25 | 27.9% | 3.9% | ||
| Q4 24 | 31.2% | -17.7% | ||
| Q3 24 | 36.0% | -5.1% | ||
| Q2 24 | 32.5% | 1.0% |
净利率PEBORGEN
| Q1 26 | 24.4% | — | ||
| Q4 25 | 27.1% | 6.7% | ||
| Q3 25 | 25.6% | 7.9% | ||
| Q2 25 | 18.5% | 8.2% | ||
| Q1 25 | 21.7% | 3.4% | ||
| Q4 24 | 24.1% | -17.4% | ||
| Q3 24 | 27.9% | -0.4% | ||
| Q2 24 | 26.3% | 2.2% |
每股收益（稀释后）PEBORGEN
| Q1 26 | $0.81 | — | ||
| Q4 25 | $0.89 | $0.24 | ||
| Q3 25 | $0.83 | $0.26 | ||
| Q2 25 | $0.59 | $0.26 | ||
| Q1 25 | $0.68 | $0.10 | ||
| Q4 24 | $0.76 | $-0.55 | ||
| Q3 24 | $0.89 | $-0.01 | ||
| Q2 24 | $0.82 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.9M | $767.6M |
| 总债务越低越好 | $691.3M | $542.2M |
| 股东权益账面价值 | $1.2B | $2.1B |
| 总资产 | $9.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.57× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PEBORGEN
| Q1 26 | $82.9M | — | ||
| Q4 25 | $189.0M | $767.6M | ||
| Q3 25 | $190.2M | $748.7M | ||
| Q2 25 | $186.1M | $708.9M | ||
| Q1 25 | $187.0M | $697.2M | ||
| Q4 24 | $217.7M | $757.4M | ||
| Q3 24 | $283.7M | $784.0M | ||
| Q2 24 | $235.9M | $809.1M |
总债务PEBORGEN
| Q1 26 | $691.3M | — | ||
| Q4 25 | $204.1M | $542.2M | ||
| Q3 25 | $227.3M | $537.9M | ||
| Q2 25 | $232.4M | — | ||
| Q1 25 | $237.0M | — | ||
| Q4 24 | $238.1M | $525.6M | ||
| Q3 24 | $236.8M | — | ||
| Q2 24 | $234.3M | — |
股东权益PEBORGEN
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.1B | $2.0B | ||
| Q2 24 | $1.1B | $2.0B |
总资产PEBORGEN
| Q1 26 | $9.6B | — | ||
| Q4 25 | $9.6B | $2.9B | ||
| Q3 25 | $9.6B | $2.9B | ||
| Q2 25 | $9.5B | $2.9B | ||
| Q1 25 | $9.2B | $2.9B | ||
| Q4 24 | $9.3B | $2.8B | ||
| Q3 24 | $9.1B | $2.8B | ||
| Q2 24 | $9.2B | $2.9B |
负债/权益比PEBORGEN
| Q1 26 | 0.57× | — | ||
| Q4 25 | 0.17× | 0.26× | ||
| Q3 25 | 0.19× | 0.26× | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.21× | 0.27× | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | $134.7M | $25.7M | ||
| Q3 25 | $14.4M | $48.1M | ||
| Q2 25 | $50.7M | $28.6M | ||
| Q1 25 | $34.3M | $15.0M | ||
| Q4 24 | $143.2M | $39.2M | ||
| Q3 24 | $34.1M | $49.3M | ||
| Q2 24 | $32.1M | $42.2M |
自由现金流PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | $128.7M | $17.6M | ||
| Q3 25 | $12.7M | $43.4M | ||
| Q2 25 | $49.2M | $21.5M | ||
| Q1 25 | $31.5M | $11.4M | ||
| Q4 24 | $136.4M | $33.6M | ||
| Q3 24 | $33.2M | $42.3M | ||
| Q2 24 | $30.2M | $37.4M |
自由现金流率PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | 109.7% | 8.9% | ||
| Q3 25 | 11.0% | 23.0% | ||
| Q2 25 | 43.0% | 11.8% | ||
| Q1 25 | 28.1% | 6.8% | ||
| Q4 24 | 122.2% | 19.3% | ||
| Q3 24 | 29.2% | 27.3% | ||
| Q2 24 | 27.4% | 24.3% |
资本支出强度PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | 5.1% | 4.1% | ||
| Q3 25 | 1.5% | 2.5% | ||
| Q2 25 | 1.3% | 3.9% | ||
| Q1 25 | 2.4% | 2.1% | ||
| Q4 24 | 6.1% | 3.2% | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | 1.7% | 3.1% |
现金转化率PEBORGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.24× | 1.93× | ||
| Q3 25 | 0.49× | 3.23× | ||
| Q2 25 | 2.39× | 1.92× | ||
| Q1 25 | 1.41× | 2.57× | ||
| Q4 24 | 5.32× | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.11× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEBO
| Net Interest Income | $90.4M | 76% |
| Noninterest Income | $28.3M | 24% |
RGEN
暂无分部数据
